|
Gene Information
|
Gene Name
|
PDE3A |
|
Gene ID
|
5139
|
|
Gene Full Name
|
phosphodiesterase 3A |
|
Gene Alias
|
HTNB; CGI-PDE; CGI-PDE A; CGI-PDE-A |
|
Transcripts
|
ENSG00000172572
|
|
Virus
|
HBV |
|
Gene Type
|
protein coding |
|
HPA Location Info
|
Plasma membrane;
|
|
Membrane Info
|
Predicted membrane proteins |
|
HPA Protein Class Info
|
Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins |
|
Uniport_ID
|
Q14432
|
|
HGNC ID
|
HGNC:8778
|
|
VEGA ID
|
OTTHUMG00000168962
|
|
OMIM ID
|
123805 |
|
String ID
|
9606.ENSP00000351957
|
|
Drugbank ID
|
BE0000436;
BE0004922
|
|
PharmGKB ID
|
PA33126
|
Target gene [PDE3A] related to VISs
Relationship between gene expression and immune infiltrating cell level
| Data ID |
Disease |
Sample number |
Sample type |
|
LIHC (TCGA) |
Liver hepatocellular carcinoma |
424 |
Liver hepatocellular carcinoma HCV (HBV+)(86), Liver hepatocellular carcinoma HCV (HBV-)(19), Liver hepatocellular carcinoma (HBV+)(209), Liver hepatocellular carcinoma (HBV+)(60), Paracancerous HCV (HBV+)(4), Paracancerous (HBV-)(28), Paracancerous (HBV+)(18) |
> Dataset: LIHC
|
|
HeatMap of cell type fractions in all samples
|
Lollipop of PDE3A expression and immune infiltrating cell level correlation result in HBV+ samples
|
PDE3A expression: Low -> High
|
|
|
|
|